Corrigendum to 'Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy' [Genes Dis (12) (2025) 101609]
Genes Dis. 2025 Oct 27;13(2):101912.
doi: 10.1016/j.gendis.2025.101912.
eCollection 2026 Mar.
1 Stem Cells Therapies in Neurodegenerative Diseases Lab, Centro de Investigación Principe Felipe (CIPF), Valencia 46012, Spain.
2 Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague 16206, Czech Republic.
3 Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Libechov 27721, Czech Republic.
4 Institute of Experimental Medicine, Czech Academy of Sciences, Department of Neuroregeneration, Prague 14220, Czech Republic.
5 Center for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0450, Norway.
6 Department of Ophthalmology, University of Split School of Medicine and University Hospital Centre, Split 21000, Croatia.
7 Department of Ophthalmology, Oslo University Hospital, Oslo 0450, Norway.
8 Department of Ophthalmology, Justus Liebig University Giessen, University Hospital Giessen and Marburg GmbH, Giessen 35392, Germany.
9 Karl Landsteiner Institute for Retinal Research and Imaging, Vienna 1030, Austria.
10 Ocular and Stem Cell Translational Research Section, National Eye Institute, NIH, Bethesda, MD 20892, USA.
11 Retinal Degeneration Lab, Department of Animal Production and Health, Public Veterinary Health and Food Science and Technology, Faculty of Veterinary Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain.
12 National Stem Cell Bank-Valencia Node, Research Centre Principe Felipe, c/Eduardo Primo Yúfera 3, Valencia 46012, Spain.